Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA2008/000355external-prioritypatent/WO2008104058A1/en
Application filed by Plasco Energy Group IncfiledCriticalPlasco Energy Group Inc
Publication of UY31081A1publicationCriticalpatent/UY31081A1/en
Esta invención provee un sistema y un método para la reformulación eficiente de un gas inicial con características asociadas en gas de salida con parámetros característicos deseados, dentro de un ambiente sustancialmente sellado, contenido, y controlado. El sistema reformulador de usa un campo energizante de gas para desasociar las moléculas iniciales del gas y las moléculas de aditivos de proceso inyectados de tipos y cantidades apropiadas, en sus componentes que luego se recombinan para formar el gas de salida con los parámetros deseados.This invention provides a system and method for the efficient reformulation of an initial gas with associated characteristics in output gas with desired characteristic parameters, within a substantially sealed, contained, and controlled environment. The reformulator system uses a gas energizing field to disassociate the initial gas molecules and injected process additive molecules of appropriate types and quantities, into their components that are then recombined to form the exit gas with the desired parameters.
UY31081A2007-05-112008-05-12
A GAS REFORMULATION SYSTEM UNDERSTANDING MEANS TO OPTIMIZE THE EFFECTIVENESS OF GAS CONVERSION
UY31081A1
(en)
Benzothiophenyl substituted purines, method for expanding stem cells comprising their culture in the presence of said substituted benzothiophenyl purines, use of said compounds in the treatment of inherited immunodeficiency, autoimmune disease and / or hematopoietic disorders.
Compounds derived from thieno [2,3-c] pyran with modulating activity of the cystic fibrosis transmembrane conductance regulator (cftr); pharmaceutical composition that includes them; Useful in the treatment of cystic fibrosis.
6-oxo-1,6-dihydropyridazines; its uses to treat a hyperproliferative disorder; the pharmaceutical composition that contains them; and its preparation processes (div. sol. 1168-06).
Herbicide combinations with an effective content of substituted 3- (2-alkoxy-4-chloro-6-alkyl-phenyl) tetramates; method for the control of unwanted plant growth because it comprises applying the components that form the aforementioned combination; use of herbicide combinations to control noxious plants.